Weight-loss drug explosion PwC described the GLP-1 market as poised for explosive growth. Its GLP-1 Trends & Impact Survey found that more than 8% of Americans already are taking GLP-1 medications, and nearly 35% are interested in these drugs for weight loss
Renowned weight loss doctors, experienced in medical weight loss
AMPK activation suppresses key fibrotic signalling pathways, including TGF-/Smad and NFB, resulting in inhibition of fibroblast proliferation and reduced ECM protein production [19]
The SURMOUNT-4 trial found that patients who continued tirzepatide 15 mg lost an additional 5.5% of body weight over 52 weeks, while those switched to placebo regained approximately 14.0% (Aronne et al., JAMA 2024)
butyricum supplementation improved constipation and overall gut health markers in elderly patients, though weight loss was not measured
May 17, 2024: Judge Pratter passes away